Crude and multivariable analysis for the association of driving distance and an unfavourable RR/MDR-TB treatment outcome
| . | . | . | Multivariable analysisa . | |||||
|---|---|---|---|---|---|---|---|---|
| . | Crude analysis . | Model 1: All patients (n = 5582) . | Model 2: Restricted to patients who are resident within 250 km of treatment facility (n = 5271) . | |||||
| Distance to treatment facility . | Crude risk ratio . | 95% CI . | Adjusted risk ratio . | 95% CI . | P-value . | Adjusted risk ratio . | 95% CI . | P-value . |
| Every 20 km | 1.017 | 1.009–1.026 | 1.013 | 1.005–1.022 | 0.001 | 1.015 | 1.000–1.030 | 0.040 |
| . | . | . | Multivariable analysisa . | |||||
|---|---|---|---|---|---|---|---|---|
| . | Crude analysis . | Model 1: All patients (n = 5582) . | Model 2: Restricted to patients who are resident within 250 km of treatment facility (n = 5271) . | |||||
| Distance to treatment facility . | Crude risk ratio . | 95% CI . | Adjusted risk ratio . | 95% CI . | P-value . | Adjusted risk ratio . | 95% CI . | P-value . |
| Every 20 km | 1.017 | 1.009–1.026 | 1.013 | 1.005–1.022 | 0.001 | 1.015 | 1.000–1.030 | 0.040 |
Adjusted for age, sex, year of registration, FQ resistance, advanced disease at diagnosis (3+ smear-positive ± cavitation on chest x-ray), extrapulmonary or pulmonary disease, prior exposure to second-line regimen and treatment site.
Crude and multivariable analysis for the association of driving distance and an unfavourable RR/MDR-TB treatment outcome
| . | . | . | Multivariable analysisa . | |||||
|---|---|---|---|---|---|---|---|---|
| . | Crude analysis . | Model 1: All patients (n = 5582) . | Model 2: Restricted to patients who are resident within 250 km of treatment facility (n = 5271) . | |||||
| Distance to treatment facility . | Crude risk ratio . | 95% CI . | Adjusted risk ratio . | 95% CI . | P-value . | Adjusted risk ratio . | 95% CI . | P-value . |
| Every 20 km | 1.017 | 1.009–1.026 | 1.013 | 1.005–1.022 | 0.001 | 1.015 | 1.000–1.030 | 0.040 |
| . | . | . | Multivariable analysisa . | |||||
|---|---|---|---|---|---|---|---|---|
| . | Crude analysis . | Model 1: All patients (n = 5582) . | Model 2: Restricted to patients who are resident within 250 km of treatment facility (n = 5271) . | |||||
| Distance to treatment facility . | Crude risk ratio . | 95% CI . | Adjusted risk ratio . | 95% CI . | P-value . | Adjusted risk ratio . | 95% CI . | P-value . |
| Every 20 km | 1.017 | 1.009–1.026 | 1.013 | 1.005–1.022 | 0.001 | 1.015 | 1.000–1.030 | 0.040 |
Adjusted for age, sex, year of registration, FQ resistance, advanced disease at diagnosis (3+ smear-positive ± cavitation on chest x-ray), extrapulmonary or pulmonary disease, prior exposure to second-line regimen and treatment site.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
